Introduction
MRI techniques as proton magnetic resonance spectroscopy ( 1 H-MRS) give non-invasive insights to diverse functional and structural alterations in patients with neurological disorders as epilepsy. [1] [2] [3] [4] [5] [6] [7] [8] [9] The multi-voxel technique refers to chemical shift imaging (CSI) which combines features of MR imaging and spectroscopy yielding data from multiple adjacent voxels eventually covering the whole brain. 10-12 1 H-MRS performed at a higher magnetic field strength as 3 T has the advantages of higher signalto-noise ratio (SNR) and improved spectral resolution in clinically acceptable scan times. Due to the advantages of high field strengths and cumulative availability of 3 T MRI multi-voxel techniques are increasingly used in clinical settings. Commonly distinguishable metabolites include total N-acetyl aspartate (tNAA), choline (tCho), myo-inositol (mI), glutamate (Glu) plus glutamine (Gln) (Glu + Gln = Glx) and creatine (tCr). In patients with idiopathic generalised epilepsy (IGE) most previous studies were implemented using the single-voxel technique (SVS), acquiring a single spectrum from a definite volume of tissue as an integral. 5, 6, [13] [14] [15] This acquisition is fairly fast (3 min) and a spectrum is easily obtained, however it provides limited information about regional distribution of brain metabolites. Only few recent studies implemented the multi-voxel technique in clinical settings with IGE. 1, 3, 4 Juvenile myoclonic epilepsy (JME), childhood absence epilepsy (CAE) and epilepsy with generalised tonic-clonic seizures only (GTCS) are the most common syndromes of IGE with distinct electroclinical features and prognosis. 16 They are considered to share absence of magnetic resonance imaging (MRI) findings and several clinical features, however differ in their predominant seizure types. 17 In previous single-and multi-voxel 1 
H-MRS
Purpose: The objective of our study was to gain further insight into the extent of local metabolic alterations in patients with idiopathic generalised epilepsy (IGE), respectively, the subgroup with generalised tonic-clonic seizures (GTCS). The extent of regional metabolic involvement perhaps indicates the key structures in generation of seizures and involvement of specific network of dysfunction.
Methods: Using the multi-voxel technique at a 3 T MRI Scanner metabolite levels of 25 age-matched healthy controls and 18 patients with GTCS were obtained from the basal ganglia, insular cortex, cingulum, hippocampus and along both hemispheres in the fronto-parietal white and grey matter.
Results: Group analysis of GTCS patients versus healthy controls revealed significant (p < 0.05) decrease of tNAA in the cortex of the central region and cingulum, but also in the thalami. Glx was elevated broadly in both hemispheres, in particular in central region, cingulum, insular cortex and left putamen, yet also in the right thalamus. Cho and mI demonstrated a significant coincidental decrease pronounced in the grey and white matter of the central region. Significant metabolic correlation (p 0.05) based on tNAA, respectively, Glx occurred between the thalamus and the central region, cingulum, putamen and medial frontal cortex. In patients with >2 tonic-clonic seizures in the last 12 months a trend towards higher Glx and lower tNAA levels was observed.
Discussion: Our results demonstrate the altered metabolic interconnection of cerebral anatomic regions in patients with GTCS, in particular the major role of basal ganglia-central region relay in seizure generation. ß 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
studies of patients with IGE, including different subgroups, metabolic alterations were mainly found in the thalamic and prefrontal tNAA levels. 1, [3] [4] [5] [6] [13] [14] [15] The neurochemical abnormalities are considered to reflect thalamocortical dysfunction, however, metabolic alterations of specific cerebral networks in particular the extend of metabolic alterations in the mentioned subgroups still remain ambiguous. 1, [3] [4] [5] [6] Using the multi-voxel technique at a 3 T scanner our purpose was to gain further insight into the extent of local metabolite alterations in patients with GTCS within grey matter sites of the basal ganglia including thalamus and putamen, insular cortex, hippocampus, cingulum and along both hemispheres in the frontoparietal white and grey matter. Our results might contribute further data regarding the extent of regional metabolic alteration, respectively, involvement of a specific network of dysfunction in patients with GTCS. Additionally, metabolic impairment in the context of seizure frequency was evaluated.
Patients and methods

Subjects-inclusion criteria
18 patients with diagnosis of GTCS 16 Therefore, we recruited adults from a limited age range, thus expecting no significant variation of the metabolites due to age. The study was approved by the local ethics committee.
Multi-voxel MR spectroscopy
Multi-voxel 1 H-MRS was performed at a 3 T Siemens Magnetom Trio (Siemens Medical Solutions, Erlangen Germany) with an 8 channel head array coil. Both patients suffering from epilepsy and healthy adults were equally examined using multi-voxel MRS sections acquired according to . The first multi-voxel section ( Fig. 1a and b) encompassed parts of the precuneus, gyrus cinguli (referred to as cingulum), as well as frontal and parietal grey and white matter (Fig. 1d) . The second multi-voxel section ( Fig. 1a and b) included the thalamus, putamen and insular cortex (Fig. 1e) . The last multi-voxel MRS section (Fig. 1c) in the hippocampi comprised the anterior portion of the hippocampus (H1) as well as the medial (H2) and posterior portion (H3) (Fig. 1f) . The positioning of the multi-voxel MRS sections was performed on voxels graphically prescribed from T2-weighted images (TR 4000 ms, TE 94 ms, slices 19-21, FOV 200, Matrix 218 Â 384). The voxels were then arranged into symmetrical pairs on each side of the midline by an experienced neuroradiologist. All measurements were performed by the same neuroradiologist to ensure reliable and comparable positioning of the sections. The caudo-mesial portion of frontal lobes was avoided owing to susceptibility artefacts generated from this region. For all three multi-voxel MRS sections a 2D-MRS sequence was used (point-resolved spectroscopy (PRESS), TE = 30 ms, TR = 1700 ms, averages 128). Corresponding unsuppressed water spectra with equal TE and TR were additionally acquired. Before data collection the automatic shim provided by the manufacturer was carried out to optimise field homogeneity. In some cases manual post-shimming was performed.
Post-processing
The following brain metabolites were selected for further analysis: totals NAA (tNAA, the sum of N-acetyl aspartate (NAA) and N-acetylaspartylglutamate (NAAG)), glutamate (Glu), glutamate (Glu) plus glutamine (Gln) (Glu + Gln = Glx), total Cho (tCho, predominantly glycerophosphocholine (GPC) and phosphocholine (PCh)), myo-Inositol (mI) and total Cr (tCr, the sum of Cr and phospocreatine (PCr)). tNAA, Glu, Glx, tCho and tCr were quantified using LCModel, 22 which is a user-independent frequency domain spectral fitting program (Fig. 2d ). LCModel quantifies metabolite values referencing to the unsuppressed water peak. Water scaling and fitting were carried out automatically. Spectra were corrected for T1-and T2-relaxation according to previous studies. 23, 24 Estimated uncertainties by Cramer-Rao
Lower Bounds (CRLB) served as main guidelines for judging the spectra of absolute metabolite values. Only metabolite spectra with LCModel estimated uncertainty of <15% standard deviation (SD) (SD < 20% for Glu and Glx) and spectra with a signal to noise ratio (SNR) above four were included in this study. Spectra with a Full Width at Half Maximum (FWHM) >0.065 ppm in the central region and a FWHM >0.08 ppm in the thalamus & insular cortex & hippocampus were not included in the study. LCModel provides estimates of the individual values of Glu and Gln, however, owing to substantial overlap even at 3 T the sum of the values of these two components (Glx) is more reliably determined than the individual components. As to Glu more than 60% of the spectra met the study criteria mentioned above (e.g. SD < 20%), therefore it was included as an additional parameter in our evaluation. Gln as a single value was not included because less than 15% of the spectra met the study criteria (SD < 20%). For further details see Hammen et al. 25 The amount of CSF in a voxel was found by manually segmenting CSF on T2-weighted images and was expressed as a percentage of voxel volume. The correction of each metabolite for CSF dilution was carried out by the formula: C corr = (C meas Â 100)/ (100 À CSF perc ). C meas refers to measured value of metabolite of the whole voxel. CSF perc corresponds to the percentage of CSF in the voxel.
We did not perform automatic morphometric segmentation on the precise amount of grey and white matter in a voxel. However, the included voxels in the respective anatomic region in both hemispheres were carefully selected by one experienced neuroradiologist preceding evaluation with LCModel. The location of a voxel, e.g. in the peripheral frontal and parietal region, was manually considered within the cortex when comprising >60% grey matter.
The number of spectra averaged for each anatomic region in both cerebral hemispheres was ( Fig. 1 ): thalamus = 2; putamen = 1; insular cortex = 3, pre-cuneus = 2, cingulum = 4; central region white matter = 3; frontal lobe white matter = 3; central region cortex = 3; medial frontal cortex = 3; lateral frontal cortex = 3.
Statistics
Statistical analysis was carried out by SPSS 15.0 and R 2.6.2.
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Normal distribution of the metabolite concentrations within the anatomic regions was checked by the Shapiro-Wilk-Test. Differences between patients and controls with respect to age were assessed using Student's t-test (Table 1) . For group analysis between healthy controls and epilepsy patients within the anatomic regions we used one-dimensional analysis of variance (ANOVA) based on p < 0.05 (Figs. 3 and 4) . Individual regional metabolic level was considered as abnormal if exceeding a plus or minus 1.5 standard deviation (SD) shift of the mean of the healthy control group ( Table  2 ). The metabolic correlation within the epileptic network (hippocampus, thalamus, putamen and central region) was tested for tNAA and Glx with Pearson's correlation (p-value 0.05). Additionally, Pearson's correlation for tNAA and Glx against frequency of seizures was applied. Analysis of variance (ANOVA) was performed for tNAA and Glx for concurrent medical treatment. Table 1 summarises the clinical data of the enclosed patients with GTCS. Figs. 3 and 4 delineate the overall extent of metabolic In summary, group analysis of GTCS patients versus healthy controls revealed significant (p < 0.05) decrease of tNAA in the cingulum and cortex of the pre-and postcentral region (in the following referred to as ''central region''). Additionally, a decrease (p < 0.05) of tNAA was observed in the thalami. Glx was elevated broadly in both hemispheres, most of all in central region, cingulum, insular cortex and left putamen. A significant increase (p < 0.05) was seen also in the right thalamus. As to Glu a significant (p > 0.05) increase was noticed in the white matter of the central region and, corresponding to Glx, pronounced in the left putamen and both insular cortex. Cho and mI demonstrated a significant coincidental decrease (p < 0.05) in particular in the grey and white matter of the central region. Moreover, Cho was significantly decreased (p < 0.05) in the left thalamus. Table 2 indicates the individual regional results of the patients with GTCS in comparison to healthy controls. In summary, tNAA was eminently reduced in patients in the grey and white matter in the central region (up to 17.6%), in the cingulum (up to 38.9%) and thalamus (up to 23.1%), while Glx showed corresponding increase in these regions (central region cortex up to 27.3%; central region white matter up to 42.9%, thalamus up to 16.7%). Additionally, Glx was elevated in the medial frontal cortex (up to 53.8%). Further significant increase of Glx was noticed also in the putamen (up to 20%) and insular cortex (up to 25%). Glu was increased in the central region (up to 17.6%), respectively in the frontal lobe white matter (up to 14.3%) as well as in the insular cortex (up to 6.2%), putamen (up to 30%) and thalamus (up to 33.3) . Cho and mI demonstrated a significant concomitant decrease mainly in the grey and white matter in the central region (up to 27.8% mI; up to 16.7% Cho), in the medial frontal cortex (up to 15.4% Cho; up to 23.1% mI) and in the thalamus (up to 16.7% Cho; up to 8.3% mI).
Results
Group analysis GTCS versus healthy controls
Individual results in comparison to healthy controls
Correlations within the epileptic network
Significant correlation within the epileptic network with p 0.05 based on tNAA, respectively Glx occurred between the thalamus and the central region, cingulum and putamen. As to Glx significant correlation was also noticed between the thalamus and the medial frontal cortex. In contrast, no significant correlation was observed in controls between thalami and other structures.
Relation to age, duration of epilepsy and seizure frequency
There was no significant correlation between tNAA or Glx and age, respectively duration of epilepsy. However, in patients with >2 tonic-clonic seizures in the last 12 months a trend towards higher Glx values and lower tNAA levels was observed in the thalamus (tNAA p = 0.08; Glx p = 0.07), insular cortex (tNAA 
Relation to concurrent medical therapy
We did not find significant difference in tNAA and Glx in any region when comparing patients with different medical treatments (ANOVA, p > 0.05).
Discussion
In agreement with recent reports applying both single-and multi-voxel techniques in different anatomic brain regions at 1.5 T scanners our results at 3 T document the major role of ''basal ganglia-central region relay dysfunction'', respectively, the extent of (sub-)network involvement in patients with GTCS. 1, 4, 5, 15 However, if the metabolic alterations, e.g. in the central region are primary or secondary to the origin of the seizures remains uncertain, particularly because of further partial metabolic abnormalities in other regions (potential sub-networks). There is relative inhomogeneity in published IGE groups, sometimes including IGE sub-syndromes that were not classifiable. Patients with GTCS in this study were selected according to the ILAE classification. 17 Additionally, we performed a voxel-based morphometric analysis to exclude missed subtle pathologic processes in conventional MRI as, e.g. cortical dysplasia or heterotopia. 18 Of course, microdysgenesis cannot be excluded using this method as well. In fact, neuropathologic studies actually demonstrated distributed cortical and subcortical microdysgenesis in patients with IGE, 27 which could form the basis of generalised involvement of the brain during seizure.
There are several theories proposed to explain the pathophysiology of generalised epilepsy. [28] [29] [30] Only few 1 H-MRS reports addressed the key structures in patients with GTCS, respectively the extent of metabolic alteration within brain networks. 1, 5, 15 We were unable to find a clinical study as to GTCS patients covering such a wide brain range. 
Metabolic alterations of tNAA, Cho and mI
In agreement with previous studies including patients with GTCS we found a reduction of tNAA and Cho in the thalamus, 1, 5, 15 however also significant reduction in the cingulum (tNAA, Cho, mI) and normal mean values in the medial frontal cortex unlike Glx. In patients suffering from JME, in contrast to GTCS, significantly reduced levels of tNAA in the medial frontal lobe were reported.
2,4-6,32 Thus, our data further support the aspect of different forms of IGE, which to a certain extent demonstrate different pathophysiologies or at least involvement of unequal (sub)-networks. 5, 13 As to tNAA a decrease is not necessarily due to reduced cell density. 33 The dysfunctional neurometabolism might arise from ''minor'' regional microdysgenesis on the basis of gene mutations. 34 
Metabolic alterations of Glx and Glu
Significant increase of Glx has proven valuable in evaluation of patients with IGE. 4, 6, 15, 35 Elevation of Glx, respectively, Glx/Cr was described as in our study in the thalamus, central region, medial frontal cortex and cingulum. 4, 15 The origin of epilepsy is believed to be caused by an inhibitory-excitatory imbalance. Glutamate (Glu) is the major excitatory neurotransmitter in the brain and elevation is known to have an excitatory effect. 36 Glx (Glu + Gln) is commonly determined, because the fitting error of the sum is much smaller than those of the single compounds. Owing to substantial overlap even at 3 T the sum of Glx is more reliably determined than the individual components. However, our study criteria admitted the inclusion of Glu although the single compound still has to be addressed with caution for reasons stated above. Thus, a substantial interpretation of different result with respect to elevation of Glx and normal Glu values, e.g. in the thalamus is not actually possible. Nevertheless, we found concomitant elevation of Glx and Glu in the putamen, insular cortex and interestingly in the fronto-parietal white matter. Glu is assumed to play an important role in the modulation of thalamic activity initiated by cortico-thalamic projections. 15 Neurons and glia are tightly coupled with respect to Glu and Gln metabolism, 37 though Gln is only synthesised in astrocytes. Disturbance of excitatory mediator turnover might contribute to seizure generation. Glial dysfunction could cause low rates of neuron-glia cycling resulting in a down regulation of the Gln synthetase. Fractional failure of the Gln synthesis results in an increased glial Glu level, which could contribute to slower Glu uptake and enhanced Glu transporter reversal.
The epileptic network
The brain is sensitive to changes within certain networks, with a consecutive engagement of the rest of the brain due to interconnected networks. 38 In agreement with a recent study using the tNAA/Cr ratio in a subgroup of patients with JME 4 we found a correlation of tNAA, respectively Glx in the thalamus and the central region, cingulum and putamen. As to Glx significant correlation was also noticed between the thalamus and the medial frontal cortex. However, we found no significant correlations in the healthy control group, therefore functional interconnection can be assumed. Only one other study including 12 JME and 8 GTCS patients reported a single correlation between thalamic and insular NAA/Cr. 1 However, to our best knowledge, no previous study reported corresponding tNAA and Glx correlations in the above mentioned anatomic brain regions. Therefore, in previous studies it was unclear whether the metabolic alterations reflected involvement of a metabolic network or was uncorrelated. The basal ganglia are involved in controlling the cortical excitability, 39 also in spread, 40 ,41 modulation 42 and persistence of seizures. 43 The feedback from the basal ganglia is mainly inhibitory, while the motor cortex sends excitatory output. A basal ganglia to cortex vicious loop with excitatory firing of cortical cells (e.g. resulting from cortical microdysgenesis) and impaired inhibitory feedback of the basal ganglia might be the underlying cause of disease. Excitotoxic lesions, an expected result of hyperexcitability, would be located in the specific networks supporting seizures, rather than distributed to the areas particularly susceptible to diffuse hypoxia or diffuse excitotoxicity, for example in the hippocampus. Therefore, it is of special interest, that we found no hippocampal metabolite alterations in patients with GTCS.
Clinical data and metabolic alterations
We were not able to demonstrate a metabolic relation to age and duration of epilepsy, however this might be due to limited patient number. As to previous studies 1, 4, 5 our results demonstrate that poorly controlled seizures are associated with more altered brain metabolites in the basal ganglia to cortex network. Whether this is related to the severity or threshold of the underlying epileptogenic pathology or to the effect of the seizures themselves remains speculative. 1 
Conclusion
Our results demonstrate certain altered metabolic interconnection of cerebral anatomic regions in patients with GTCS, in particular the major role of the basal ganglia-central region relay in seizure generation. However, the primary locations of seizure generation and therewith the underlying substrates (e.g. microdysgenesis; cause-effect issue) remain ambiguous. To what extend different clinical IGE syndromes may depend on specific modifying genes still has to be addressed. 44, 45 Table 2 Summary of GTCS patients with abnormal higher or lower metabolic values using a 1.5 standard deviation cut-off from the mean of the control group. Each field shows the included number of patients depending on the inclusion criteria (see methodical part) and underneath the corresponding percentage. tCr is not shown owing to unremarkable results [Abbreviations: r-cr-C = right central region Cortex; l-cr-C = left central region Cortex; r-cr-WM = right central region White Matter; l-cr-WM = left central region White Matter; r-Ci = right cingulum; l-Ci = left cingulum; r-pCu = right pre-cuneus; l-pCu = left pre-cuneus; r-lf-C = right lateral frontal Cortex; l-lf-C = left lateral frontal Cortex; r-f-WM = right frontal lobe White Matter; l-f-WM = left frontal lobe White Matter; r-mf-C = right medial frontal Cortex; l-mf-C = left medial frontal Cortex; r-In = right insular; lIn = left insular; r-Th = right thalamus; l-Th = left thalamus; r-P = right putamen; l-P = left putamen].
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